< Back to previous page
Researcher
Niels Vandewalle
- Keywords:Medicine
- Disciplines:Hematology, Cancer therapy, Applied immunology, Nuclear imaging
Affiliations
- Hematology (Research group)
Member
From22 Mar 2021 → Today - Faculty of Medicine and Pharmacy (Faculty)
Member
From14 Sep 2020 → Today - Basic (bio-) Medical Sciences (Department)
Member
From1 Nov 2020 → Today - Basic (bio-) Medical Sciences (Department)
Member
From1 Oct 2020 → 31 Oct 2020 - Basic (bio-) Medical Sciences (Department)
Member
From1 Oct 2020 → 31 Oct 2020 - Faculty of Medicine and Pharmacy (Faculty)
Member
From21 Sep 2018 → 24 Jun 2020
Projects
1 - 1 of 1
- Nanobody-based individualized AXL targeting to reverse immune suppression and overcome therapy resistance in Acute Myeloid LeukemiaFrom1 Nov 2020 → TodayFunding: FWO fellowships
Publications
1 - 3 of 3
- Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma(2023)
Authors: Rong Fan, Hatice Satilmis, Niels Vandewalle, Emma Verheye, Philip Vlummens, Anke Maes, Catharina Muylaert, Elke De Bruyne, Eline Menu, Holly Evans, et al.
- Targeting the β2 -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism(2023)
Authors: Hatice Satilmis, Emma Verheye, Philip Vlummens, Inge Oudaert, Niels Vandewalle, Rong Fan, Jennifer M Knight, Nathan De Beule, Gamze Ates, Ann Massie, et al.
Pages: 69–80 - AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies(2019)
Authors: Siyang Yan, Niels Vandewalle, Nathan De Beule, Sylvia Faict, Ken Maes, Elke De Bruyne, Eline Menu, Karin Vanderkerken, Kim De Veirman
Pages: 1-17